期刊文献+

层层自组装法制备肝素微囊及其性能研究 被引量:3

Preparation of Alginate-Ca Microcapsules by LbL Self-assembly and Its Anticoagulant Performance
在线阅读 下载PDF
导出
摘要 以海藻酸钙微核为模板,采用带正电荷的聚稀丙基铵盐酸盐(PAH)和带负电荷的肝素钠(HEP),通过层层自组装(Layer-by-layer,LbL)技术构建具有多层膜结构和抗凝血活性的药物微囊。采用荧光倒置显微镜、SEM、动态光散射仪、Zeta电位仪和抗凝血仪等进行表征。结果表明,制备的海藻酸钙微核粒径约为1.5μm,尺寸均匀、分散性佳;以ALG为模板制得的LbL微囊具备典型的核壳式结构;Zeta电位检测表明,随包膜层数的增加,微囊的电位呈正负交替的变化趋势;通过体外凝血时间(PT、APTT、TT)检测微囊抗凝血活性,比较了分别以PAH和HEP作为最外层时的生物活性,其中以HEP为最外层的显著增强了材料的抗凝血性能,同时随着组装层数的增加,也提高了微囊的抗凝血性能。 The template of microcapsules are prepared by dispersing alginate(ALG) in emulsion, which are encapsulated with poly(allylamine)(PAH) and low molecular weight heparin(HEP) by means of layer-by-layer(LbL) self-assembly to form complex microcapsules with a multi-layer structure. SEM, dynamic light scattering(DLS), zeta potential analyzer, ultraviolet spectrophotometer and antithrombogenicity are used to characterize the microcapsules. The results show that the average diameter of calcium alginate microcapsules is 1. Stem; the LbL microcapsules with ALG templete have a typical core-shell structure; the surface zeta-potentials of microcapsule alternatively shifted with increasing microcapsules layers; the in vitro antithrombogenicity representing the activity of microcapsules is deter- mined by the method of activated partial thromboplast in time(APTT), prthromb in time(PT) and thromb in time (TT) test. The LbL microcapsules loaded HEP have anticoagulation effects when the outer layer of mierocapsules is HEP.
出处 《材料导报》 EI CAS CSCD 北大核心 2010年第6期22-25,共4页 Materials Reports
基金 北京市科技基金资助项目(Y0905001000091)
关键词 海藻酸钠 层层自组装 低分子肝素 抗凝血材料 alginate, LbL self-assembly, LMWH, anticoagulant materials
  • 相关文献

参考文献16

  • 1冯品珍,鲁剑涛.肝素化聚甲基丙烯酸的合成及其抗凝血性研究[J].功能高分子学报,1995,8(1):35-40. 被引量:9
  • 2Keuren J F W, Wielders S J H, Willems G M, et al. Thromhogenieity of polysaceharide-coated surfares[J]. Biomaterials, 2003,24 : 1917.
  • 3王华杰,王林嵩,王瑾晔.玉米醇溶蛋白-肝素微球的制备和缓释[J].科学技术与工程,2003,3(6):557-560. 被引量:4
  • 4Levine M, et al. A comparison of lowrnolecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis[J]. J Med Chem, 1996,234(11) : 677.
  • 5Gleb B, Sukhorukov, Edwin Donath, et al. Stepwise polyelectrolyte assembly on particles surfaces: A novel approach to colloid design[J]. Polyrn Adv Techn, 1998,9 : 759.
  • 6Decher G, Hong J D. Buildup of ultrathin multilayer films by a self-assembly process. 1. Consecutive adsorption of anionic and cationic bipolar amphiphiles on charged surfaces [J]. Macromol Chem, 1991,46 : 321.
  • 7Zhu Huiguang, Rohit S, Michael J. Spontaneous loading of positively charged macromolecules into alginate-templated polyelectrolyte multilayer microcapsules[J]. Biomacromolecules,2005(6) .-2221.
  • 8Marika R, Seppo R, Paavo H, et al. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes[J]. Biolog Chem, 2001,36 : 33875.
  • 9顾晋伟,杨新林,王俐勇,朱鹤孙.丝素蛋白膜表面的等离子体磺酸化及体外抗凝血性能[J].高技术通讯,2001,11(8):7-10. 被引量:28
  • 10Decher G. Fuzzy nanoassemblies toward layered polymeric multieomposites[J]. Science, 1997,277(5330) : 1232.

二级参考文献29

  • 1[1]Gentry P W, Alexander B. Specific coagulation factor adsorption to insoluble heparin. Biochem Biophys Res Commun, 1973;50:500-508
  • 2[2]Hommes D, et al. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis.Ann Intern Med, 1992;116:279-284
  • 3[3]Iaskey M A, et al. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcomes in patients with unstable angina. Am J Cardiol,1990;65(22): 1425-1429
  • 4[4]Theroux P, et al. Reactivation of unstable angina after discontinuation of heparin. N Engl J Med, 1992;327:141-145
  • 5[5]Scati T. (Studio sulla Calciparina nell ' Angina e nella Thrombosi Ventricolare nell' Infarto) Group, Randomized controlled trial of subcutaneous calciumheparin in acute myocardial infarction. Lancet, 1989;2:182-186
  • 6[6]Hettleman B D, et al. Three days of heparin pretreatment reduces major complications of coronary angioplasty in patients with unstable angina. J Am Coll Cardiol, 1990; 15(2): 154A
  • 7[7]Edelman E R, Nathan A, Katada M, Gates J, Karnovsky M J. Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials, 2000;21:2279-2286
  • 8[8]Fischman D L, Leon M B, Baim D S, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med, 1994;331:496-501
  • 9[9]Lau K W, Sigwart U. Restenosis an accelerated arterioparthy: pathophysiology, preventive strategies and research horizons. In: ed. Edelman E R. Molecular interventions and local drug delivery. Philadelphia: W B Saunders, 1995:1-28
  • 10[10]Rogers C, Edlman E R, Endovascular stent design dictates experimental restenosis and thrombosis. Circulation, 1995;91:2995-3001

共引文献38

同被引文献36

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部